Attenuation of muscle wasting in murine C2C12myotubes by epigallocatechin-3-gallate

Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy

(2011) S.A. Reed et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia

(2011) Hang Wang et al.   CANCER LETTERS

Tea catechins prevent contractile dysfunction in unloaded murine soleus muscle: A pilot study

(2011) Noriyasu Ota et al.   NUTRITION

Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture

(2010) André Bartholome et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention

(2010) Joshua D. Lambert et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo

(2010) Phan LCHB Tran et al.   BMC CANCER

Mechanism of attenuation of protein loss in murine C2C12 myotubes by d-myo-inositol 1,2,6-triphosphate

(2009) Steven T. Russell et al.   EXPERIMENTAL CELL RESEARCH

Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-α and angiotensin II by β-hydroxy-β-methylbutyrate

(2008) Helen L. Eley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by β-hydroxy-β-methylbutyrate

(2008) Helen L. Eley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Free Zn2+ enhances inhibitory effects of EGCG on the growth of PC-3 cells

(2008) Shi-li Sun et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Green tea polyphenols as a natural tumour cell proteasome inhibitor

(2008) Q. P. Dou et al.   INFLAMMOPHARMACOLOGY